Michael Schmidt
Stock Analyst at Guggenheim
(4.12)
# 477
Out of 4,876 analysts
113
Total ratings
62.07%
Success rate
9.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Reiterates: Buy | $80 | $37.51 | +113.28% | 4 | Jun 25, 2025 | |
| AVBP ArriVent BioPharma | Reiterates: Buy | $45 | $22.46 | +100.40% | 2 | Jun 24, 2025 | |
| ADCT ADC Therapeutics | Maintains: Buy | $7 → $10 | $2.77 | +261.01% | 5 | Jun 13, 2025 | |
| URGN UroGen Pharma | Maintains: Buy | $40 → $15 | $13.19 | +13.77% | 1 | May 23, 2025 | |
| MRSN Mersana Therapeutics | Reiterates: Buy | $5 | $0.32 | +1,462.50% | 3 | May 16, 2025 | |
| KYMR Kymera Therapeutics | Reiterates: Buy | $52 | $44.26 | +17.49% | 1 | May 12, 2025 | |
| SWTX SpringWorks Therapeutics | Reiterates: Neutral | $47 | $46.99 | +0.03% | 3 | May 12, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $12 → $10 | $2.67 | +275.23% | 4 | May 9, 2025 | |
| ONC BeOne Medicines | Maintains: Buy | $348 → $350 | $239.91 | +45.89% | 3 | May 8, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $30 → $10 | $3.37 | +196.74% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $9.24 | +246.32% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $16 | $7.73 | +106.99% | 5 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.72 | +69.49% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $52.86 | +106.21% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.23 | +651.40% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $4.18 | +235.33% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $25 | $8.86 | +182.17% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $92 | $70.24 | +30.98% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $35.00 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $10.42 | - | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $43.22 | -2.82% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.56 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $128.21 | - | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.93 | +582.59% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.24 | +545.16% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.00 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.88 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.60 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.19 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $8.25 | +312.12% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $0.67 | +2,877.96% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.46 | - | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.30 | +1,830.50% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $4.59 | +553.59% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $3.21 | +709.97% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.50 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $33.83 | +136.48% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.41 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $3.17 | +73.50% | 2 | Nov 7, 2017 |
Revolution Medicines
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $37.51
Upside: +113.28%
ArriVent BioPharma
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $22.46
Upside: +100.40%
ADC Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $2.77
Upside: +261.01%
UroGen Pharma
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $13.19
Upside: +13.77%
Mersana Therapeutics
May 16, 2025
Reiterates: Buy
Price Target: $5
Current: $0.32
Upside: +1,462.50%
Kymera Therapeutics
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $44.26
Upside: +17.49%
SpringWorks Therapeutics
May 12, 2025
Reiterates: Neutral
Price Target: $47
Current: $46.99
Upside: +0.03%
Compass Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.67
Upside: +275.23%
BeOne Medicines
May 8, 2025
Maintains: Buy
Price Target: $348 → $350
Current: $239.91
Upside: +45.89%
Relay Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.37
Upside: +196.74%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $9.24
Upside: +246.32%
May 2, 2025
Maintains: Buy
Price Target: $32 → $16
Current: $7.73
Upside: +106.99%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.72
Upside: +69.49%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $52.86
Upside: +106.21%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.23
Upside: +651.40%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $4.18
Upside: +235.33%
Mar 20, 2025
Maintains: Buy
Price Target: $35 → $25
Current: $8.86
Upside: +182.17%
Mar 18, 2025
Downgrades: Neutral
Price Target: $92
Current: $70.24
Upside: +30.98%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $35.00
Upside: -
Feb 26, 2025
Reiterates: Buy
Price Target: n/a
Current: $10.42
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $43.22
Upside: -2.82%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.56
Upside: -
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $128.21
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $2.93
Upside: +582.59%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.24
Upside: +545.16%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $32.00
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.88
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.60
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $8.25
Upside: +312.12%
Jun 27, 2023
Downgrades: Neutral
Price Target: $20
Current: $0.67
Upside: +2,877.96%
Jan 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $20.46
Upside: -
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $1.30
Upside: +1,830.50%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $4.59
Upside: +553.59%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $3.21
Upside: +709.97%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $33.83
Upside: +136.48%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $6.41
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $3.17
Upside: +73.50%